CG肿瘤制药

最新新闻

• 评级变动
  Bank of America Securities Reaffirms Their Buy Rating on CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/7
• 评级变动
  Morgan Stanley Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $93
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Analysts' Opinions Are Mixed on These Healthcare Stocks: CG Oncology, Inc. (CGON) and Zimmer Biomet Holdings (ZBH)
  TipRanks · 2026/8/13
• 评级变动
  A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $85 to $108
  \u5e02\u573a\u8d44\u8baf · 2026/8/8
• 评级变动
  H.C. Wainwright Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $100
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 评级变动
  Analysts' Top Healthcare Picks: Annexon Biosciences (ANNX), CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/7
• 评级变动
  Analysts' Top Healthcare Picks: InflaRx (IFRX), CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/7
• 评级变动
  A Quick Look at Today's Ratings for CG Oncology(CGON.US), With a Forecast Between $79 to $100
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  CG Oncology, Inc. (CGON) Gets a Buy From Piper Sandler
  TipRanks · 2026/8/7
• 评级变动
  Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), Natera (NTRA) and Pfizer (PFE)
  TipRanks · 2026/6/23
• 评级变动
  Analysts Have Conflicting Sentiments on These Healthcare Companies: Phibro Animal Health (PAHC), Universal Health (UHS) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/7/28
• 评级变动
  RBC Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $81
  \u5e02\u573a\u8d44\u8baf · 2026/6/30
• 评级变动
  Analysts Offer Insights on Healthcare Companies: ATyr Pharma (ATYR) and CG Oncology, Inc. (CGON)
  TipRanks · 2026/7/10
• UBS Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $90
  \u5e02\u573a\u8d44\u8baf · 2026/8/21
• Analysts' Top Healthcare Picks: CG Oncology, Inc. (CGON), Opus Genetics (IRD)
  TipRanks · 2026/9/10
• 评级变动
  LifeSci Capital Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $108
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• UBS Keeps Their Buy Rating on CG Oncology, Inc. (CGON)
  TipRanks · 2026/8/20
• 评级变动
  Analysts Offer Insights on Healthcare Companies: CG Oncology, Inc. (CGON), Alnylam Pharma (ALNY) and Connect Biopharma Holdings (CNTB)
  TipRanks · 2026/6/30
• Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating, Maintains Target Price $85
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• Truist Financial Maintains CG Oncology(CGON.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/9/10

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。